stockrow
Friday 6 November 2026
Export VWAV’s income statement to Excel — free account
visionwave holdings, inc.
VWAV Industrials Aerospace & Defense
- EPS
- −8,315.8%
- Free cash flow
- −10,453.1%
- Total debt
- +2,734.0%
Quarter to June 2026, against a year earlier
1.39
0.22
−13.66%
Follow VWAV
Alert me
| Dec '17 | Sep '20 | Sep '21 | Dec '21 | Dec '22 | Dec '23 | Sep '24 | Dec '24 | Sep '25 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | — | 8.94 | 2.53 | 0.03 | 0.06 | 0.04 | 0.00 | 0.19 | 0.19 |
Net Debt/EBITDA |
— | 0.00 | 0.00 | 1.09 | (0.89) | (0.49) | 0.00 | (0.77) | (0.53) | (0.53) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 1.28% | 3.01% | 0.00% | 26.68% | 217.80% | 0.00% |
Debt/Equity |
— | 0.00 | — | 0.00 | (0.74) | (0.27) | 0.00 | (0.17) | (0.50) | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.00 | (0.95) | 1.20 | (14.51) | 15.99 | — | 0.99 | 0.43 | 0.43 |
Capex/Depreciation |
— | 0.00 | 0.00 | — | — | — | — | — | — | — |
Interest Coverage |
— | — | — | (263.80) | (0.92) | — | — | — | (113.68) | (113.68) |
| — | 0.00% | 0.00% | 0.00% | 0.91% | 2.32% | 0.00% | 28.76% | 73.66% | 55.51% | |
| — | 0.00% | 0.00% | (0.79%) | 0.07% | (0.11%) | 0.00% | (46.11%) | (202.85%) | (486.31%) | |
ROIC |
— | 0.00% | 0.00% | (2.22%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (117.67%) |
Return on Tangible Assets |
— | 0.00% | 0.00% | (76.30%) | (3.40%) | 1.53% | 0.00% | 16.09% | 55.51% | 55.51% |
Average Days of Receivables |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | — | — | — | — | — | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | — | — | — | — | — | 0.00% | 0.00% |
Free Cash Flow per Share |
— | 0.00 | 0.00 | (1.39) | (1.45) | (2.94) | — | (4.27) | (4.83) | (0.24) |
Cash per Share |
— | — | — | 1.79 | 0.04 | 0.75 | 0.00 | 0.05 | 3.89 | 0.19 |
Shareholders Equity per Share |
— | 0.00 | — | 48.32 | (2.64) | (11.80) | 0.00 | (29.65) | (20.09) | 0.00 |
Interest Debt per Share |
— | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | — | 48.32 | (2.64) | (11.80) | 0.00 | (29.65) | (20.09) | 0.00 |
Free Cash Flow |
— | 0.00 | 0.00 | (0.33) | (0.68) | (0.91) | — | (0.86) | (2.84) | (2.84) |
Working Capital |
— | — | 0.11 | 0.36 | (1.39) | (3.70) | (0.08) | (5.41) | (11.80) | (11.80) |
Capital Expenditures |
— | 0.00 | 0.00 | — | — | — | — | — | — | — |
Net Current Asset Value |
— | 0.00 | 0.12 | (58.13) | (72.66) | (35.77) | (0.08) | (9.73) | (11.80) | (11.80) |
| Other line items | ||||||||||
Quick Ratio |
— | — | 0.00 | 1.81 | 0.01 | 0.06 | 0.04 | 0.00 | 0.17 | 0.17 |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | — | — | — | — | — | — | — |
Cash ROIC |
— | 0.00% | 0.00% | (2.77%) | 220.89% | 37.13% | 0.00% | 17.35% | 77.85% | (34.82%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | — | — | — | 0.00 |
Accounts Payable Turnover |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
— | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | 0.00 | 0.00 | (1.39) | (1.45) | (2.94) | — | (4.27) | (4.83) | (0.24) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | — | — | — | 0.12 |
Average Payables |
— | — | — | — | 0.24 | 0.53 | 0.40 | 0.49 | 2.44 | 3.92 |
Average Assets |
— | 0.00 | 0.06 | 35.21 | 70.88 | 51.91 | 16.18 | 1.89 | 3.23 | 1.35 |
Average Common Equity |
— | — | — | — | 5.16 | (2.45) | (1.86) | (3.03) | (8.89) | (11.80) |
Capex to Sales |
— | 0.00 | 0.00 | — | — | — | — | — | — | — |
Columns are period end dates · fundamentals updated 26 Oct 2026